Issue 35, 2019

Near-infrared photothermally activated nanomachines for cancer theragnosis

Abstract

Near-infrared photothermal-activated nanomaterials are emerging as a promising tool in precise cancer theranostics. This Frontier article highlights the recent advances of photothermal-activated nanoagents in biomedical applications, namely photothermal-initiated drug/contrast agent release, gene silencing, programmed targeting and gas theranostics. In the end, we give a perspective on the further development of photothermal-sensitive nanomedicines.

Graphical abstract: Near-infrared photothermally activated nanomachines for cancer theragnosis

Article information

Article type
Frontier
Submitted
21 jun. 2019
Accepted
19 jul. 2019
First published
19 jul. 2019

Dalton Trans., 2019,48, 13120-13124

Near-infrared photothermally activated nanomachines for cancer theragnosis

Z. He and J. Zhu, Dalton Trans., 2019, 48, 13120 DOI: 10.1039/C9DT02623A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements